“Our partnership with Avance Clinical is incredibly valuable to KMUH as it allows us to connect with innovative biotech companies from around the world and bring cutting-edge clinical trials to Taiwan,” said Jaw-Yuan Wang, Superintendent of Kaohsiung Medical University Chung-Ho Memorial Hospital.
“By combining our clinical research expertise and diverse patient population with Avance Clinical’s global trial management capabilities, we can accelerate the development of new therapies and provide our patients with earlier access to groundbreaking treatments.”
Avance Clinical CEO Yvonne Lungershausen emphasized the importance of Taiwan in the company’s broader clinical trial strategy.
“This agreement with Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) strengthens our ability to support biotechs looking to leverage Asia’s advanced clinical research ecosystem. Taiwan offers an exceptional regulatory environment, rapid study start-up timelines, and access to highly experienced investigators, making it a prime location for early-phase trials.”
“As biotechs transition from early-phase to later-phase trials, seamless patient recruitment and regulatory expertise become critical. Our expanded presence in Taiwan, alongside our established operations in South Korea, ensures biotechs benefit from a streamlined path to multi-regional trials, faster patient enrolment, and world-class trial data recognized by global regulatory agencies,” Lungershausen said.
This partnership further reinforces Avance Clinical’s Asia Advantage, a strategic initiative designed to provide biotech sponsors with accelerated clinical trial solutions across Australia, New Zealand, Taiwan, and South Korea, offering faster study start-up, regulatory flexibility, and high-quality data collection.
About Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
KMUH located in Kaohsiung City, Taiwan, is a leading medical institution known for its comprehensive healthcare services, advanced medical research, and dedication to patient care. Established in 1957, KMUH serves as the teaching hospital for Kaohsiung Medical University and has grown into a major center for clinical education, innovative research, and high-quality medical treatment in southern Taiwan. The hospital is recognized for its expertise across a broad range of specialties, including oncology, cardiology, neurology, and organ transplantation, and is committed to integrating cutting-edge technology with compassionate care to improve patient outcomes.
www.kmuh.org.tw/english/
About Avance Clinical
Avance Clinical is a leading global CRO specializing in early to late-phase clinical trials for biotech companies. Headquartered in Australia, Avance Clinical delivers faster, more flexible, and high-quality clinical trial solutions with a strong focus on regulatory compliance and patient-centric research. With a global footprint spanning Australia, New Zealand, Asia, North America, and Europe, Avance Clinical offers comprehensive support from preclinical consulting to Phase I-III trials, ensuring biotech sponsors achieve efficient trial execution and regulatory success.
